Nature Mental Health, Published online: 23 April 2026; doi:10.1038/s44220-026-00645-1
This longitudinal study using data from two large nationwide cohorts in Sweden and Finland examined the comparative effectiveness of mood stabilizers, antipsychotics and their combinations in reducing psychiatric hospitalization risk for people with bipolar disorder. The authors found that certain drug combinations, particularly clozapine-based regimens and long-acting injectable antipsychotics with lithium, were linked to lower relapse risk than lithium alone.
via Nature Mental Health https://ift.tt/dCNvkKu


Leave a Reply